Custom mRNA vaccines tested against deadly recurrent brain tumors
NCT ID NCT06389591
Summary
This early-stage study is testing personalized mRNA vaccines for adults with recurrent glioblastoma, an aggressive brain cancer. Researchers will create vaccines using genetic material from each patient's own tumor tissue, combined with a standard mRNA component. The main goals are to see if these custom vaccines can be reliably manufactured and to check their safety in up to 24 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UF Health
Gainesville, Florida, 32608, United States
Conditions
Explore the condition pages connected to this study.